BRIDGEBIO PHARMA INC's ticker is and the CUSIP is 10806XAB8. A total of 41 filers reported holding BRIDGEBIO PHARMA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $7,269,963 | +20771222.9% | 438,214 | -3.9% | 0.02% | – |
| Q4 2022 | $35 | -99.9% | 455,775 | +11.5% | 0.00% | – |
| Q3 2022 | $41,000 | -64.7% | 408,945 | -64.8% | 0.00% | – |
| Q2 2022 | $116,000 | +39.8% | 1,160,780 | +51.5% | 0.00% | – |
| Q1 2022 | $83,000 | -47.8% | 765,955 | -19.7% | 0.00% | – |
| Q4 2021 | $159,000 | -45.4% | 953,533 | +56.4% | 0.00% | -100.0% |
| Q3 2021 | $291,000 | +7175.0% | 609,776 | +8697.8% | 0.00% | – |
| Q1 2021 | $4,000 | – | 6,931 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BRAIDWELL LP | 141,500,000 | $63,675,000 | 2.13% |
| ARISTEIA CAPITAL, L.L.C. | 156,841,000 | $70,578,450 | 1.41% |
| Affinity Asset Advisors, LLC | 7,500,000 | $3,410,048 | 1.34% |
| CONTRARIAN CAPITAL MANAGEMENT, L.L.C. | 8,500,000 | $3,782,500 | 0.94% |
| TFG Asset Management GP Ltd | 10,000,000 | $4,623,611 | 0.66% |
| Context Capital Management, LLC | 17,035 | $7,890 | 0.58% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 47,329,000 | $18,813 | 0.52% |
| SILVERBACK ASSET MANAGEMENT LLC | 5,000,000 | $2,287,850 | 0.32% |
| MACKAY SHIELDS LLC | 14,611,000 | $6,574,950 | 0.17% |
| Ionic Capital Management LLC | 1,400,000 | $644,740 | 0.15% |